drugset / Trial / NCT00313729

Temozolomide in Treating Patients With Low-Grade Glioma

NCT00313729 ↗

Phase 2 Completed 120 enrolled University of California, San Francisco
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well temozolomide works in treating patients with supratentorial low-grade glioma.

Timeline

Start
1999-05
Primary completion
2014-09-25
Completion
2017-06-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral